Skip to main content
OpenTrials
Completed

NCT Number: NCT02048137

Transcranial Direct Current Stimulation to Reduce Chronic Pain in Patients With Chronic Inflammatory Bowel Diseases

In the study we test whether transcranial direct current stimulation can reduce the perception of pain in patients with chronic inflammatory bowel diseases.

Hypothesis: Transcranial direct current stimulation can reduce the perception of pain in patients with chronic inflammatory bowel diseases.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Charite University Medicine

Berlin, 12200, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Inflammatory bowel disease
  • Chronic pain (more than 3 months)
  • Pain (VAS > 3/10)

Exclusion criteria

  • Contraindication to transcranial direct current stimulation
  • Pregnancy
  • Sever internal or psychiatric condition

Treatment and study plan

Transcranial Direct Current Stimulation

Device

Primary outcomes

  1. Pain pressure threshold

    Time frame: 1 week

Secondary outcomes

  1. Visual analoug scale - pain

    Time frame: 1 week

Other outcomes

  1. Quality of life

    Time frame: 3 weeks

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Acronym: tDCS in IBD

Important dates

Study start
2014
Primary completion
2016
First posted
Jan 29, 2014
Registry last updated
Jan 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.